Home › Asset managers › Compare 2025-2026 › Charles Schwab vs JPMorgan
Charles Schwab 2025-2026 · JPMorgan 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 5,267 | 4,646 | 518 | 103 | 90.0% | 89.6% |
| Board proposals | 4,618 | 4,121 | 421 | 76 | 90.7% | 90.3% |
| E&S shareholder proposals | 128 | 104 | 9 | 15 | 92.0% | 91.8% |
| Other items | 521 | 421 | 88 | 12 | 82.7% | 82.7% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
497 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Charles Schwab | JPMorgan |
|---|---|---|---|---|---|---|
| ACCO BRANDS CORPORATION | May 19, 2026 | Approval of an amendment to the 2022 ACCO Brands Corporation Incentive Plan to increase the number of shares available for future grant and eliminate fungible share counting provisions with respect to new awards. Compensation |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| ACLARIS THERAPEUTICS, INC. | June 4, 2026 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying the proxy card. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| ADEIA INC. | May 7, 2026 | To approve an amendment to the Amended and Restated 2020 Equity Incentive Plan to increase the number of shares reserved for issuance by an additional 10,700,000 shares of common stock; and Compensation |
Board | For | FOR 4 funds |
AGAINST 4 funds |
| AES CORP | April 29, 2026 | Approval, on an advisory basis, of the Company's executive compensation. Say-on-Pay |
Board | For | FOR 15 funds |
AGAINST 2 funds |
| AGCO CORPORATION | April 23, 2026 | Non-binding advisory resolution to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 14 funds |
AGAINST 6 funds |
| AGREE REALTY CORPORATION | May 14, 2026 | To approve, by non-binding vote, executive compensation. Say-on-Pay |
Board | For | FOR 15 funds |
AGAINST 7 funds |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | To approve an amendment to our Second Amended and Restated 2013 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 8,000,000 shares. Compensation |
Board | For | FOR 14 funds |
AGAINST 5 funds |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | To approve, on an advisory basis, our named executive officer compensation. Say-on-Pay |
Board | For | FOR 16 funds |
AGAINST 5 funds |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | May 13, 2026 | To cast a non-binding, advisory vote on a resolution to approve the compensation of the Company's named executive officers, as more particularly described in the accompanying Proxy Statement. Say-on-Pay |
Board | For | FOR 17 funds |
AGAINST 10 funds |
| ALIGN TECHNOLOGY, INC. | May 20, 2026 | Advisory Vote to Approve the Compensation of our Named Executive Officers Say-on-Pay |
Board | For | FOR 15 funds |
AGAINST 5 funds |
| ALLOGENE THERAPEUTICS, INC. | June 18, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| ALPHABET INC. | June 5, 2026 | Advisory vote to approve compensation awarded to named executive officers Say-on-Pay |
Board | For | AGAINST 19 funds |
FOR 27 funds |
| AMBARELLA, INC. | June 26, 2026 | To approve an amendment and restatement of the Ambarella, Inc. 2021 Equity Incentive Plan. Compensation |
Board | For | AGAINST 5 funds |
FOR 3 funds |
| AMERICAN ELECTRIC POWER COMPANY, INC. | April 28, 2026 | Approval, on an advisory basis, of the Company's named executive officer compensation. Say-on-Pay |
Board | For | FOR 15 funds |
AGAINST 7 funds |
| AMNEAL PHARMACEUTICALS, INC. | May 6, 2026 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 3 funds |
| ANIKA THERAPEUTICS, INC. | June 18, 2026 | Advisory vote on the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| ANIKA THERAPEUTICS, INC. | June 18, 2026 | Approval of the Amendment to the Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan. Compensation |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| ANNALY CAPITAL MANAGEMENT, INC. | June 10, 2026 | Advisory approval of the Company's executive compensation. Say-on-Pay |
Board | For | FOR 13 funds |
AGAINST 6 funds |
| APA CORPORATION | May 21, 2026 | Advisory vote to approve the compensation of APA's named executive officers Say-on-Pay |
Board | For | FOR 17 funds |
AGAINST 6 funds |
| APPIAN CORPORATION | June 3, 2026 | To approve the Appian Corporation Amended and Restated 2017 Equity Incentive Plan. Compensation |
Board | For | AGAINST 5 funds |
FOR 2 funds |
| APPLIED OPTOELECTRONICS, INC. | June 4, 2026 | To approve the 2026 equity incentive plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 4 funds |
| APTIV PLC | April 29, 2026 | Say-on-Pay - To approve, by advisory vote, executive compensation. Say-on-Pay |
Board | For | FOR 13 funds |
AGAINST 15 funds |
| ARCHER AVIATION INC. | June 26, 2026 | Approval of the redomestication of the Company from Delaware to Texas by conversion. Extraordinary Transactions |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| ARCHER AVIATION INC. | June 26, 2026 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| ARCUS BIOSCIENCES, INC. | June 11, 2026 | To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of Arcus Biosciences for its fiscal year ending December 31, 2026. Audit-related |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| ARCUTIS BIOTHERAPEUTICS, INC. | June 5, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| ARDELYX, INC | June 16, 2026 | To approve the amendment to the Amended and Restated 2014 Equity Incentive Award Plan, or the Restated Plan, to increase the maximum number of shares of common stock that may be delivered pursuant to awards granted under the Restated Plan by 9,000,000 shares. Compensation |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| ARISTA NETWORKS, INC. | May 29, 2026 | Approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 15 funds |
FOR 19 funds |
| ASANA, INC. | June 8, 2026 | Approval, on an advisory basis, of the compensation of the Company's named executive officers ("Say-on-Pay"). Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 2 funds |
| ATRICURE, INC. | May 18, 2026 | Advisory vote on the compensation of our named executive officers as disclosed in the proxy statement for the 2026 Annual Meeting. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 3 funds |
| AVANOS MEDICAL,INC. | April 21, 2026 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 2 funds |
| B&G FOODS, INC. | May 21, 2026 | Approval, by non-binding advisory vote, of executive compensation. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| BANK OF HAWAII CORPORATION | April 24, 2026 | Ratification of the Re-appointment of Ernst & Young LLP for 2026. Audit-related |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| BANK OF HAWAII CORPORATION | April 24, 2026 | Say on Pay - An advisory vote on executive compensation. Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 1 fund |
| BANNER CORPORATION | May 20, 2026 | Election of Director: Connie R. Collingsworth Director Elections |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| BANNER CORPORATION | May 20, 2026 | Election of Director: John R. Layman Director Elections |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| BANNER CORPORATION | May 20, 2026 | Election of Director: Roberto R. Herencia Director Elections |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| BANNER CORPORATION | May 20, 2026 | Ratification of the Audit Committee's appointment of Baker Tilly US, LLP as the independent registered public accounting firm for the year ending December 31, 2026 Audit-related |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| BAXTER INTERNATIONAL INC. | May 5, 2026 | Approval of the Baxter International Inc. Second Amended and Restated 2021 Incentive Plan Compensation |
Board | For | FOR 14 funds |
AGAINST 4 funds |
| BECTON DICKINSON & CO. | January 27, 2026 | Advisory Vote to Ratify Named Executive Officers' Compensation Say-on-Pay |
Board | For | FOR 17 funds |
AGAINST 11 funds |
| BELDEN INC. | May 21, 2026 | Amendment and Restatement of the Belden 2021 Long Term Incentive Plan. Compensation |
Board | For | FOR 10 funds |
AGAINST 3 funds |
| BENCHMARK ELECTRONICS, INC. | May 28, 2026 | To approve an amendment to the Benchmark Electronics, Inc. 2019 Omnibus Incentive Compensation Plan to increase the total number of authorized shares of the Company's common stock available for grant hereunder by 1,800,000 shares; and Compensation |
Board | For | FOR 7 funds |
AGAINST 4 funds |
| BLACKROCK, INC. | May 20, 2026 | Approval, in a non-binding advisory vote, of the compensation for named executive officers. Say-on-Pay |
Board | For | AGAINST 17 funds |
FOR 8 funds |
| BLUELINX HOLDINGS | May 14, 2026 | Proposal to approve an Amendment to the 2021 Long-Term Incentive Plan to increase the number of shares of common stock reserved for Issuance under the plan. Compensation |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| BORGWARNER INC. | April 29, 2026 | Approve the Amended and Restated BorgWarner Inc. 2023 Stock Incentive Plan. Compensation |
Board | For | FOR 12 funds |
AGAINST 4 funds |
| BORR DRILLING LIMITED | May 20, 2026 | To re-elect Alexandra Kate Blankenship as a Director of the Company. Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| BORR DRILLING LIMITED | May 20, 2026 | To re-elect Neil J. Glass as a Director of the Company. Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| BORR DRILLING LIMITED | May 20, 2026 | To re-elect Patrick Schorn as a Director of the Company. Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| BOX, INC. | June 25, 2026 | To approve an amendment to our Amended and Restated 2015 Equity Incentive Plan to increase the number of shares reserved for issuance by 7,200,000 shares. Compensation |
Board | For | AGAINST 8 funds |
FOR 7 funds |
| BREAD FINANCIAL HOLDINGS, INC. | May 19, 2026 | RATIFICATION OF THE SELECTION OF DELOITTE & TOUCHE LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR 2026 Audit-related |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| BRIGHT HORIZONS FAMILY SOLUTIONS INC. | June 3, 2026 | To approve, on an advisory basis, the 2025 compensation paid by the Company to its Named Executive Officers. Say-on-Pay |
Board | For | FOR 13 funds |
AGAINST 10 funds |
| BROADCOM INC | April 20, 2026 | Advisory vote to approve the named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 18 funds |
FOR 37 funds |
| BROWN & BROWN, INC. | May 6, 2026 | To approve, on an advisory basis, the compensation of named executive officers. Say-on-Pay |
Board | For | FOR 15 funds |
AGAINST 6 funds |
| BURLINGTON STORES, INC. | May 19, 2026 | Approval, on a non-binding advisory basis, of the compensation of Burlington Stores, Inc.'s named executive officers ("Say-On-Pay") Say-on-Pay |
Board | For | FOR 13 funds |
AGAINST 23 funds |
| BXP, INC. | May 21, 2026 | To approve, by non-binding, advisory resolution, the Company's named executive officer compensation. Say-on-Pay |
Board | For | FOR 17 funds |
AGAINST 3 funds |
| Boston Beer Company, Inc. | May 27, 2026 | Advisory vote to approve our named executive officers' executive compensation. Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 3 funds |
| CABLE ONE, INC. | May 14, 2026 | To approve the Cable One, Inc. 2026 Omnibus Incentive Compensation Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| CABLE ONE, INC. | May 14, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers for 2025. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| CAESARS ENTERTAINMENT, INC. | June 9, 2026 | ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION. Say-on-Pay |
Board | For | FOR 12 funds |
AGAINST 2 funds |
| CALIFORNIA WATER SERVICE GROUP | May 20, 2026 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 3 funds |
| CALLAWAY GOLF COMPANY | May 21, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 4 funds |
| CARRIAGE SERVICES, INC. | May 12, 2026 | Approve our proposed Second Amendment to the Company's 2017 Omnibus Incentive Plan. Compensation |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CATHAY GENERAL BANCORP | May 18, 2026 | Election of Class III Directors, to be elected for the term ending 2029: Richard Sun Director Elections |
Board | For | AGAINST 7 funds |
FOR 2 funds |
| CDW CORPORATION | May 21, 2026 | To approve, on an advisory basis, named executive officer compensation. Say-on-Pay |
Board | For | FOR 15 funds |
AGAINST 10 funds |
| CELCUITY INC. | May 14, 2026 | To approve the Celcuity Inc. 2026 Stock Incentive Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 2 funds |
| CELCUITY INC. | May 14, 2026 | To approve the Celcuity Inc. Amended and Restated Employee Stock Purchase Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 2 funds |
| CEVA, INC. | June 2, 2026 | Advisory vote to approve named executive officer compensation Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| CHEMED CORPORATION | May 18, 2026 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | FOR 14 funds |
AGAINST 10 funds |
| CHESAPEAKE UTILITIES CORPORATION | May 6, 2026 | Approve on an advisory non-binding basis the compensation of the Company's Named Executive Officers. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 7 funds |
| CIPHER DIGITAL INC. | June 2, 2026 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 3 funds |
| CLEAR CHANNEL OUTDOOR HOLDINGS, INC. | May 12, 2026 | A proposal to approve, on an advisory, non-binding basis, the specified compensation that will or may be paid or may become payable to the Company's named executive officers in connection with the Merger (the "Advisory Compensation Proposal"). Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 6 funds |
| CLEARWATER ANALYTICS HOLDINGS, INC. | May 6, 2026 | To approve by, advisory (non-binding) vote, the compensation that may be paid or become payable to the named executive officers of the Company in connection with the consummation of the Merger. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 3 funds |
| CLEARWATER PAPER CORPORATION | May 7, 2026 | Approve the Clearwater Paper Corporation 2026 Stock Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| CLEARWAY ENERGY, INC. | April 29, 2026 | To approve a Second Amended and Restated Certificate of Incorporation of Clearway Energy, Inc. (the "Amended Charter") that would (i) provide that each share of Class A common stock, par value $0.01 per share ("Class A common stock"), will be convertible into one share of Class C common stock, par value $0.01 per share, (ii) provide that such conversion (the "Class A Conversion") will occur automatically at 12:01 A.M. (Eastern Time) on the second business day following the filing of the Amended Charter, (iii) provide that, from and after the Class A Conversion, Clearway Energy, Inc. will not have authority to issue or reissue Class A common stock and certain provisions relating to the Class A common stock will have no further force or effect, (iv) reduce the number of authorized shares of Class A common stock to 34,613,853 and (v) update certain other historical matters. Capital Structure |
Board | For | AGAINST 9 funds |
FOR 7 funds |
| CLEVELAND-CLIFFS INC. | May 14, 2026 | Approval, on an advisory basis, of Cleveland-Cliffs Inc.'s named executive officers' compensation. Say-on-Pay |
Board | For | FOR 12 funds |
AGAINST 5 funds |
| CLOUDFLARE, INC. | June 30, 2026 | Approval and adoption of amendments to establish the Class C common stock. Capital Structure |
Board | For | AGAINST 8 funds |
FOR 10 funds |
| CLOUDFLARE, INC. | June 30, 2026 | Approval and adoption of amendments to implement a stock split in which (i) each share of Class A common stock would become one share of Class A common stock and one share of Class C common stock; and (ii) each share of Class B common stock would become one share of Class B common stock and one share of Class C common stock. Capital Structure |
Board | For | AGAINST 8 funds |
FOR 10 funds |
| CLOUDFLARE, INC. | June 30, 2026 | Approval and adoption of amendments to increase the number of authorized shares of Class A common stock from 2,250,000,000 to 4,500,000,000. Capital Structure |
Board | For | AGAINST 8 funds |
FOR 10 funds |
| CLOUDFLARE, INC. | June 30, 2026 | Approval and adoption of amendments to provide for the equal treatment of shares of Class A common stock, Class B common stock, and Class C common stock in connection with dividends and distributions, certain transactions, and upon our liquidation, dissolution, or winding up. Capital Structure |
Board | For | AGAINST 8 funds |
FOR 10 funds |
| CLOUDFLARE, INC. | June 30, 2026 | Approval of the amendment and restatement of our Amended and Restated 2019 Employee Stock Purchase Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 10 funds |
| CLOUDFLARE, INC. | June 30, 2026 | Approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 12 funds |
| CNA FINANCIAL CORPORATION | April 29, 2026 | An advisory (non-binding) vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 14 funds |
AGAINST 1 fund |
| COLUMBIA FINANCIAL, INC. | June 25, 2026 | The ratification of the appointment of KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026 Audit-related |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| COMMUNITY FINANCIAL SYSTEM, INC. | May 20, 2026 | Ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2026. Audit-related |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| COMPX INTERNATIONAL INC. | May 20, 2026 | Nonbinding advisory vote approving named executive officer compensation. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| CONSTELLIUM SE | May 21, 2026 | Re-appointment of Mr. John Ormerod as a director for a term of three years Director Elections |
Board | For | FOR 4 funds |
AGAINST 4 funds |
| CORCEPT THERAPEUTICS INCORPORATED | May 21, 2026 | To approve an amendment to the Corcept Therapeutics Incorporated 2024 Incentive Award Plan to increase the number of shares available thereunder and clarify certain other language in the plan. Compensation |
Board | For | AGAINST 11 funds |
FOR 3 funds |
| COREWEAVE, INC. | June 8, 2026 | Election of Class I Director: Michael Intrator Director Elections |
Board | For | WITHHOLD 9 funds |
FOR 1 fund |
| CORPAY, INC. | May 7, 2026 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 15 funds |
FOR 29 funds |
| COSTAR GROUP, INC. | June 23, 2026 | Proposal to approve, on an advisory basis, the Company's executive compensation. Say-on-Pay |
Board | For | AGAINST 16 funds |
FOR 2 funds |
| COTERRA ENERGY INC. | May 4, 2026 | To approve, on a non-binding advisory basis, the compensation that may be paid or become payable to Coterra's named executive officers that is based on or otherwise relates to the merger (the ''Advisory Compensation Proposal''); and Say-on-Pay |
Board | For | FOR 15 funds |
AGAINST 9 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Binding vote on maximum equity for members of the Board of Directors from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders. Compensation |
Board | For | AGAINST 5 funds |
FOR 4 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Binding vote on maximum equity for members of the Executive Committee from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders. Compensation |
Board | For | AGAINST 5 funds |
FOR 4 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Non-binding advisory vote on the 2025 Compensation Report. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 4 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 4 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Re-election of Briggs W. Morrison, M.D. Director Elections |
Board | For | FOR 5 funds |
AGAINST 4 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Re-election of Sandesh Mahatme, LL.M. Director Elections |
Board | For | AGAINST 5 funds |
FOR 4 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Re-election of Simeon J. George, M.D. Director Elections |
Board | For | FOR 5 funds |
AGAINST 4 funds |
| DARLING INGREDIENTS INC. | May 7, 2026 | Approve, on an advisory basis, executive compensation. Say-on-Pay |
Board | For | FOR 11 funds |
AGAINST 4 funds |
| DAUCH CORPORATION | April 30, 2026 | Approval of Amended and Restated 2018 Omnibus Incentive Plan. Compensation |
Board | For | FOR 7 funds |
AGAINST 1 fund |
Page 1 of 5 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.